- Harrow Health (Nasdaq:Hrow) It is planned to publish the results of earnings in Q4 on Monday, March 17, after the market closure.
- Consensus EPS estimate is $ 0.04 (+120.0% y/y) and the consensus revenue assessment is $ 58.41 million (+60.6% y/y).
- In the last 2 years, Hrow
